Biosimilars patent
![](https://moginrubin.com/wp-content/uploads/2017/04/mr-news-icon.png)
Pharma: Consumer Groups, States Support Reviving Generic Drugs Antitrust Case Against AbbVie
Pro-consumer organizations — Consumer Action and U.S. Public Interest Research Group — and 20 states have filed amici curiae briefs with the Seventh Circuit U.S.…
![](https://moginrubin.com/wp-content/uploads/2017/04/JMS-Headshot-e1545433311752.jpg)
Getting Biosimilars to Market: A Virtual Panel Discussion
Getting Biosimilars to Market, a recent virtual panel moderated by MoginRubin’s Joy Sidhwa, examines commercial challenges facing biosimilars from both the patent and the antitrust…